April 01, 2026

FDA Approves Lilly’s Foundayo Oral GLP-1 Pill

The newly approved therapy offers a noninjectable option that can be taken at any time of day without food or water restrictions.

Conexiant

March 31, 2026

AHA Updates Heart-Healthy Dietary Guidance

Nine evidence-based features now frame cardiovascular risk reduction across the life course, with sharper language on alcohol, ultraprocessed foods, and plant protein

Conexiant

March 30, 2026

Knee OA Pain: Inulin vs Physiotherapy Effects

Prebiotic supplementation and physiotherapy show distinct and complementary effects on functional and pain sensitivity outcomes.

Conexiant

March 26, 2026

Obesity’s Cancer Role Underestimated

A proposed framework highlights potential sources of bias in current estimates

Conexiant

March 26, 2026

Ultrasound Models Estimate Whole-Body Muscle Mass

New equations incorporating cross-sectional area improve estimation accuracy.

Conexiant

March 20, 2026

Obesity Care Lags Behind Advances in Treatment

A 2026 expert perspective highlights system-level gaps in care delivery

Conexiant

March 19, 2026

Wegovy HD Secures FDA Approval

Semaglutide 7.2 mg achieved 20.7% mean weight loss in STEP UP trials.

Conexiant

March 19, 2026

Sleeve vs Gastric Bypass: Nutrient Intake at 1 Year

Investigators analyze 4-day food records and supplement reports from 285 patients at seven Swedish metabolic and bariatric centers in a substudy of the randomized BEST trial.

Conexiant

March 18, 2026

AAP, NASPGHAN Issue Guidance on Faltering Weight in Children

New recommendations standardize diagnosis and aim to reduce unnecessary interventions in early childhood growth concerns.

Conexiant

March 17, 2026

Women and Liver Fibrosis Risk: New Insights

Study reveals sex-specific differences in fibrosis associations

The Pathologist